Differential effects of tyrosine kinase inhibitors on tumor necrosis factor and nitric oxide production by murine macrophages

Journal of Infectious Diseases

Volumn 174, Issue 3, 1996, Pages 638-642

  Orlicek, Shari L ^b   Meals, Elizabeth ^b   English, B Keith ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GENISTEIN; HERBIMYCIN A; LIPOPOLYSACCHARIDE; NITRIC OXIDE SYNTHASE; PROTEIN TYROSINE KINASE INHIBITOR; RECOMBINANT GAMMA INTERFERON; TUMOR NECROSIS FACTOR; TYRPHOSTIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNOREGULATION; INHIBITION KINETICS; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN PHOSPHORYLATION; REPRODUCIBILITY;

EID: 0029781529     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/174.3.638     Document Type: Article

References (15)

1. Raetz C, Ulevitch R, Wright S, Sibley C, Ding A, Nathan C. Gram-negative endotoxin: an extraordinary lipid with profound effects on eukaryotic signal transduction. FASEB J 1991;5:2652-60.
2. Weinstein SL, Gold MR, DeFranco AL. Bacterial lipopolysaccharide stimulates protein tyrosine phosphorylation in macrophages. Proc Natl Acad Sci USA 1991;88:4148-52.
3. Nathan C, Xie Q. Regulation of biosynthesis of nitric oxide. J Biol Chem 1994;269:13725-8.
4. Beutler B, Cerami A. The biology of cachectin/TNF - a primary mediator of the host response. Annu Rev Immunol 1989;7:625-55.
5. Harald HH, Schmidt W, Walter U. NO at work. Cell 1994;78:919-25.
6. Evans T, Carpenter A, Kinderman H, Cohen J. Evidence of increased nitric oxide production in patients with the sepsis syndrome. Circ Shock 1993;41:77-81.
7. Gardlund B, Sjolin J, Nilsson A, Roll M, Wickerts CJ, Wretlind B. Plasma levels of cytokines in primary septic shock in humans: correlation with disease severity. J Infect Dis 1995;172:296-301.
8. English BK, Ihle JN, Myracle A, Yi T. Hck tyrosine kinase activity modulates tumor necrosis factor production by murine macrophages. J Exp Med 1993; 178:1017-22.
9. Beaty CD, Franklin TL, Uehara Y, Wilson CB. Lipopolysaccharide-induced cytokine production in human monocytes: role of tyrosine phosphorylation in transmembrane signal transduction. Eur J Immunol 1994; 24:1278-84.
10. Dong Z, Qi X, Xie K, Fidler IJ. Protein tyrosine kinase inhibitors decrease induction of nitric oxide synthase activity in lipopolysaccharide-responsive and lipopolysaccharide-nonresponsive murine macrophages. J Immunol 1993;151:2717-24.
11. Novogrodsky A, Vanichkin A, Patya M, Gazit A, Osherov N, Levitzki A. Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors. Science 1994;264:1319-22.
12. Levitzki A, Gazit A. Tyrosine kinase inhibition: an approach to drug development. Science 1995;267:1782-8.
13. Zhang X, Morrison DC. Lipopolysaccharide-induced selective priming effects on tumor necrosis factor-α and nitric oxide production in mouse peritoneal macrophages. J Exp Med 1993; 177:511-6.
14. lyn J Biol Chem 1993;268:20725-8.
15. Ihle JN, Witthuhn BA, Quelle FW, et al. Signaling by the cytokine receptor superfamily: JAKs and STATs. Trends Biochem Sci 1994;19:222-7.